 This form of active targeting was found to be successful when utilizing transferrin as the cell-specific ligand.The transferrin was conjugated to the nanoparticle to target tumor cells that possess transferrin-receptor mediated endocytosis mechanisms on their membrane.This means of targeting was found to increase uptake, as opposed to non-conjugated nanoparticles.